Donal O'Connor - Director, Theravance Biopharma, Inc

As of May 20, 2019


Donal O'Connor Net Worth

  • Net worth is estimated to be at least $1.17M
  • Owns at least 27,571 units of Theravance Biopharma, Inc stock
  • Sold an estimated value of $81.83K recently at Theravance Biopharma, Inc

Donal O'Connor Trading

  • Largest sale of shares was 4,000 units , worth over $81.83K on May 20, 2019
  • In total has made about 1 transaction recently
  • Usually trades in May, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Donal O'Connor Mailing Address

  • Mailing address is C/o Perrigo Company Plc 515 Eastern Avenue Allegan MI 49010 MI

Theravance Biopharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick E Winningham 2020 $1,014,455 - $579,646 - $579,646 $6,045 $6,577,746
Rick E Winningham 2019 $983,710 - $473,906 - $473,906 $5,496 $5,932,411
Rick E Winningham 2018 $956,600 $74,767 $690,154 - $690,154 $5,000 $2,522,841
Andrew A. Hindman 2020 $551,608 - $265,278 - $265,278 $5,920 $2,097,950
Andrew A. Hindman 2019 $315,000 $175,000 $216,000 $2,204,956 $216,000 - $3,757,956
Brett Haumann 2020 $572,569 - $213,589 - $213,589 $53,267 $2,742,625
Brett Haumann 2019 $543,047 - $170,000 - $170,000 $42,382 $2,464,280
Brett Haumann 2018 $497,810 $34,125 $315,000 - $315,000 $414,300 $1,517,194
Vijay Sabesan 2020 $407,677 - $760,326 - $760,326 $6,541 $3,077,744
Bradford J. Shafer 2020 $556,321 - $264,999 - $264,999 $6,045 $2,730,565
Bradford J. Shafer 2019 $537,403 - $215,611 - $215,611 $6,983 $2,468,848
Bradford J. Shafer 2018 $518,080 $33,770 $311,726 - $311,726 $5,000 $1,124,537
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm

Theravance Biopharma, Inc Insider Trading

  • The most recent transaction was 8,829 units sold on March 11, 2021 by Philip Worboys worth over $176.58K
  • In the last 6 years, insiders at Theravance Biopharma, Inc sold an estimated value of $50.75M and bought an estimated value of $26.3M
  • The most active traders are Bradford Shafer, EVP,  Brett Haumann, Chief Medical Officer,  and Philip Worboys, SVP
  • Insider trading is most common in February, with the busiest year in 2018

Theravance Biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1